• Herbalife recently expanded its global Fuel Like Ronaldo campaign with a detailed “4 R” post-match recovery framework and was named to TIME’s America’s Best Companies 2026 list, while also partnering with FIFA 1904 for a wellness-focused activation at its SoHo headquarters.
• Taken together, these initiatives underline Herbalife’s push to link its brand more closely with science-based sports nutrition, soccer culture, and workplace quality.
• We’ll now examine how Herbalife’s TIME recognition for employee satisfaction, financial strength, and ESG transparency may influence its broader investment narrative.

Outshine the giants: these 15 early-stage AI stocks could fund your retirement.

Herbalife Investment Narrative Recap

To own Herbalife, you have to believe its shift toward science-backed wellness, personalized nutrition, and a stable distributor base can offset past earnings pressure and leverage concerns. The Ronaldo recovery campaign, TIME “Best Companies” recognition, and FIFA 1904 partnership all support the wellness and brand story, but do not materially change the near term focus on execution ahead of upcoming earnings or the key risk around regulatory and reputational scrutiny of its multi-level marketing model.

Among the recent announcements, Herbalife’s inclusion on TIME’s America’s Best Companies 2026 list is most relevant. It speaks directly to employee satisfaction, perceived financial strength, and ESG transparency, which sit alongside debt management and margin discipline as core elements of the current investment debate. For investors watching for a sustained turnaround in profitability and distributor engagement, this recognition may reinforce confidence in the company’s internal footing, even if it does not resolve the bigger structural risks.

Yet even as Herbalife earns workplace and brand accolades, investors still need to consider the unresolved regulatory and legal overhang tied to its multi-level marketing model...

Herbalife's narrative projects $5.6 billion revenue and $317.3 million earnings by 2029. This requires 2.9% yearly revenue growth and an earnings increase of about $77.5 million from $239.8 million today.

Uncover how Herbalife's forecasts yield a $18.33 fair value, a 50% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already assuming revenue could reach about US$5.7 billion and earnings near US$386.8 million by 2029, so Ronaldo-linked momentum and TIME recognition might either support that bullish view or expose how ambitious it really is, underscoring just how differently you and other investors might weigh regulatory risk versus growth potential.

Explore 6 other fair value estimates on Herbalife - why the stock might be worth over 6x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Herbalife research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Herbalife research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Herbalife's overall financial health at a glance.

Seeking Other Investments?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.